Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency [ID6415]

  • In development
  • GID-TA11503
  • Expected publication date: 

Documents

Documents created during the development process.

Draft guidance: 1

Declaration of interests

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6415

Topic selection